Market Cap (In KRW)
176.28 Billion
Revenue (In KRW)
361.1 Billion
Net Income (In KRW)
27.43 Billion
Avg. Volume
63.98 Thousand
- Currency
- KRW
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 5950.0-10760.0
- PE
- -
- EPS
- 0.0
- Beta Value
- 1.067
- ISIN
- KR7000020008
- CUSIP
- -
- CIK
- -
- Shares
- 27717960.0
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. Doh Joon Yoon
- Employee Count
- -
- Website
- https://www.dong-wha.co.kr
- Ipo Date
- 2000-01-04
- Details
- Dongwha Pharm Co., Ltd. manufactures and sells pharmaceutical products in South Korea. It offers ethical products in the areas of alimentary system, antibiotic, cardiovascular/metabolic disease, NSAID/respiratory system, muscle relaxant/musculoskeletal system, nervous system, and dermatological/urinary system; OTC products in the areas of alimentary system, cold remedy, NSAID/respiratory system, dermatological, mouth and teeth, hepatic protector, nutrient, tonic, topic analgesic, antihistamines, sore throat, and others; quasi drugs; health subsidiary foods; foods and drinks; and cosmetics. The company was founded in 1897 and is based in Seoul, South Korea.
More Stocks
-
RAJSREESUGRajshree Sugars and Chemicals Limited
RAJSREESUG
-
SILINVSIL Investments Limited
SILINV
-
SMPEF
-
GHAVGrand Havana, Inc.
GHAV
-
PNGZFGCX Metals Limited
PNGZF
-
ALTD
-
FWZ
-
CC